However, the reluctance in adoption of rapid acting insulin due to the side effect, such as hypoglycemia, may hinder the growth of the industry. Conversely, untapped market and undiagnosed population ...

Insulin glulisine is a rapidly acting analogue with a pharmacokinetic profile that is similar to those of insulin lispro and insulin aspart. [48] It is created by substituting lysine for ...

(Figure 1) Given below are recombinant products that could be candidates for biosimilars: Recombinant Proteins: Insulin human (1982-2019); somatropin ... alefacept (2003); laronidase (2003); insulin ...

Hypoglycemia, including its risk factors and remediation, should be discussed routinely with patients receiving treatment with insulin or sulfonylurea/glinide drugs, especially those with a ...

While weight loss can result in reducing insulin resistance, improving the way you eat can also help to lower your insulin levels. The key is to choose foods that don't raise your insulin even more.

Levy, A. L., Nature, 174, 126 (1954).